Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Phibro Animal Health
PAHC
$1.43B
| $3.92M | 0.01% |
139,528
+23,087
| +20% | +$651K |
|
1602
Sterling Infrastructure
STRL
$14.9B
| $3.91M | 0.01% |
422,363
+266,498
| +171% | +$2.43M |
|
|
WW
1603
CALL
DELISTED
WW International
WW
| $3.89M | 0.01% |
+250,000
| New | +$3.44M |
|
|
UN
1604
DELISTED
Unilever NV New York Registry Shares
UN
| $3.89M | 0.01% |
+78,330
| New | +$3.51M |
|
|
EMKR
1605
DELISTED
Emcore Corp
EMKR
| $3.89M | 0.01% |
43,220
+32,251
| +294% | +$2.94M |
|
1606
Consolidated Edison
ED
$39.6B
| $3.88M | 0.01% |
+50,000
| New | +$3.76M |
|
1607
Ascendis Pharma A/S
ASND
$16.6B
| $3.88M | 0.01% |
138,383
-88,421
| -39% | -$2.23M |
|
1608
FS KKR Capital
FSK
$3.33B
| $3.87M | 0.01% |
+98,764
| New | +$4.04M |
|
1609
PPG Industries
PPG
$25.3B
| $3.85M | 0.01% |
36,654
-481,674
| -93% | -$48.8M |
|
|
PRTK
1610
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.85M | 0.01% |
+200,000
| New | +$3.15M |
|
1611
OR Royalties Inc
OR
$7.29B
| $3.84M | 0.01% |
+346,318
| New | +$3.82M |
|
|
EPZM
1612
DELISTED
Epizyme, Inc
EPZM
| $3.83M | 0.01% |
223,623
+78,801
| +54% | +$1.05M |
|
1613
Commercial Metals
CMC
$7.4B
| $3.82M | 0.01% |
199,694
-63,052
| -24% | -$1.29M |
|
|
HAPN
1614
Happen Inc
HAPN
$2.11B
| $3.8M | 0.01% |
138,361
+35,252
| +34% | +$1M |
|
1615
Insight Enterprises
NSIT
$4.42B
| $3.79M | 0.01% |
+92,350
| New | +$3.78M |
|
|
INST
1616
DELISTED
Instructure, Inc.
INST
| $3.79M | 0.01% |
161,904
+98,750
| +156% | +$2.24M |
|
1617
Itron
ITRI
$4.32B
| $3.78M | 0.01% |
62,325
-110,055
| -64% | -$6.84M |
|
1618
Anika Therapeutics
ANIK
$286M
| $3.77M | 0.01% |
86,892
+50,613
| +140% | +$2.42M |
|
1619
Invesco
IVZ
$14.4B
| $3.77M | 0.01% |
123,089
-222,044
| -64% | -$6.94M |
|
1620
Pembina Pipeline
PBA
$28B
| $3.77M | 0.01% |
+118,888
| New | +$3.78M |
|
1621
Granite Construction
GVA
$5.42B
| $3.75M | 0.01% |
74,776
-451,684
| -86% | -$24M |
|
|
AHL
1622
DELISTED
ASPEN Insurance Holding Limited
AHL
| $3.75M | 0.01% |
72,111
-167,907
| -70% | -$9.31M |
|
1623
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.3B
| $3.75M | 0.01% |
129,122
+55,678
| +76% | +$1.61M |
|
|
BRKL
1624
DELISTED
Brookline Bancorp
BRKL
| $3.73M | 0.01% |
238,108
+177,099
| +290% | +$2.79M |
|
1625
NVR
NVR
$17.1B
| $3.71M | 0.01% |
1,763
-2,731
| -61% | -$5.17M |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.